What are the diagnostic criteria and treatment for ST-Elevation Myocardial Infarction (STEMI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ST-Elevation Myocardial Infarction (STEMI): Diagnostic Criteria and Treatment

STEMI is defined as a clinical syndrome characterized by symptoms of myocardial ischemia with persistent ST-segment elevation on ECG and subsequent release of cardiac biomarkers, requiring immediate reperfusion therapy to reduce mortality and morbidity. 1

Diagnostic Criteria

ECG Criteria

  • ST elevation at the J point in at least 2 contiguous leads of:
    • ≥2 mm (0.2 mV) in men or ≥1.5 mm (0.15 mV) in women in leads V2–V3 1
    • ≥1 mm (0.1 mV) in other contiguous chest leads or limb leads 1
  • ST depression in ≥2 precordial leads (V1–V4) may indicate posterior wall infarction 1
  • Multilead ST depression with ST elevation in lead aVR may indicate left main or proximal LAD occlusion 1
  • Hyperacute T-wave changes may be observed in early phases of STEMI 1

Clinical Presentation

  • Characteristic symptoms of myocardial ischemia (chest pain/discomfort lasting 10-20 minutes or more) 1
  • Pain may radiate to neck, jaw, or left arm 1
  • Atypical presentations (especially in elderly) may include fatigue, dyspnea, faintness, or syncope 1

Diagnostic Workup

  • 12-lead ECG should be performed and shown to an experienced physician within 10 minutes of emergency department arrival 1
  • If initial ECG is not diagnostic but clinical suspicion remains high, serial ECGs at 5-10 minute intervals or continuous 12-lead ST-segment monitoring should be performed 1
  • Cardiac troponin is the preferred biomarker for diagnosis 1
  • Transthoracic echocardiography may help identify wall motion abnormalities when ECG is difficult to interpret 1

Treatment Algorithm

Immediate Management (First Medical Contact)

  1. Reperfusion Strategy Decision

    • Primary PCI is the preferred reperfusion strategy if it can be performed within 120 minutes of first medical contact 1, 2, 3
    • If PCI cannot be performed within 120 minutes, administer fibrinolytic therapy immediately (within 10 minutes of STEMI diagnosis) 1, 2
  2. Initial Pharmacotherapy

    • Administer loading dose of aspirin (162-325 mg) 1, 2
    • Administer P2Y12 inhibitor loading dose 2, 4:
      • Prasugrel 60 mg (preferred if no history of stroke/TIA and age <75 years) 4
      • Clopidogrel 600 mg (if prasugrel contraindicated) 5
      • Ticagrelor (preferred over clopidogrel if no contraindications) 2
    • Administer anticoagulant (unfractionated heparin, enoxaparin, or bivalirudin) 2
    • For pain relief: morphine sulfate (2-4 mg IV, with 2-8 mg IV every 5-15 minutes as needed) 1
    • Sublingual nitroglycerin (0.4 mg every 5 minutes, up to three doses) if no contraindications 1

Primary PCI Approach

  • Perform coronary angiography with intent to perform PCI 1
  • Use radial access preferentially over femoral access to reduce bleeding complications 2
  • Implant drug-eluting stents as standard of care 2
  • Consider treatment of severe non-infarct-related artery stenosis before hospital discharge 2
  • In cardiogenic shock, consider non-infarct-related artery PCI during the index procedure 2

Fibrinolytic Therapy Approach (if PCI not available within 120 minutes)

  • Administer fibrinolytic therapy within 30 minutes of hospital arrival 1
  • Consider transfer for rescue PCI if fibrinolysis fails, as evidenced by 1:
    • Cardiogenic shock
    • Severe heart failure/pulmonary edema
    • Hemodynamically compromising ventricular arrhythmias
    • Less than 50% resolution of ST-segment elevation 90 minutes after fibrinolysis

Post-Reperfusion Care

  • Implement dual antiplatelet therapy (DAPT) with aspirin plus P2Y12 inhibitor, typically for one year 2
  • Initiate beta-blockers within 24 hours in hemodynamically stable patients 1
  • Initiate ACE inhibitors/ARBs and statins before discharge 1, 6
  • Monitor for complications including arrhythmias, heart failure, and mechanical complications 2

Special Considerations and Pitfalls

Special Scenarios

  • For patients presenting 12-24 hours after symptom onset, primary PCI may still be considered if evidence of ongoing ischemia exists 2
  • In patients with LBBB, ST elevation analysis may be difficult and should not be considered diagnostic of acute MI in isolation 1
  • Right-sided ECG leads should be obtained in patients with inferior STEMI to screen for right ventricular infarction 1

Common Pitfalls

  • Delaying reperfusion therapy due to atypical presentations or ECG patterns 2
  • Failing to recognize ST depression in anterior leads (V1-V3) as possible posterior myocardial infarction 2
  • Waiting for cardiac biomarker results before initiating reperfusion therapy 1
  • Routine use of intravenous beta-blocker therapy in the acute phase may increase risk of cardiogenic shock 1

High-Risk Features

  • Killip class II-IV at admission (acute heart failure) 6
  • Left ventricular ejection fraction <35% 6
  • Age older than 65 years 6
  • Anterior location of myocardial infarction 6

The management of STEMI requires a coordinated systems-based approach with emphasis on minimizing total ischemic time to improve survival and reduce complications. Time is muscle - every effort should be made to establish reperfusion as quickly as possible, with primary PCI being the preferred strategy when timely access is available.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.